Status:
UNKNOWN
Risk Prediction in Type II Diabetics With Ischemic Heart Disease
Lead Sponsor:
Thebiosignals.com
Conditions:
Type-2 Diabetes Mellitus
Ischemic Heart Disease
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to test whether cardiac autonomic dysfunction predicts is a prognostic marker in type-2 diabetics with ischemic heart disease
Detailed Description
In patients with type 2-diabetes and ischemic heart disease autonomic function might be seriously affected. In the present study, markers of cardiac autonomic dysfunction, repolarization and respirat...
Eligibility Criteria
Inclusion
- type-2 diabetes
- coronary artery disease
Exclusion
- age \>80 years
- acute coronary syndrome
- life expectancy \<1 year
- unable to give informed consent
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2016
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01422057
Start Date
January 1 2010
End Date
January 1 2016
Last Update
February 6 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiology
Tübingen, Tübingen, Germany, 72076